Fuh Hwa 15+ Year Pharmaceuticals Bond ETF (00759B.TWO) Price

Fuh Hwa 15+ Year Pharmaceuticals Bond ETF is offered by Fuh Hwa, a leading player in the field of passive investments.

The ISIN of Fuh Hwa 15+ Year Pharmaceuticals Bond ETF is TW00000759B0.

The total expense ratio of Fuh Hwa 15+ Year Pharmaceuticals Bond ETF is 0.51%, which means that investors pay 51.00 TWD per 10,000 TWD in investment capital annually.

The ETF is listed in TWD.

European investors may incur additional costs for currency exchange and transaction fees.

No, Fuh Hwa 15+ Year Pharmaceuticals Bond ETF does not comply with the EU UCITS investor protection directives.

Fuh Hwa 15+ Year Pharmaceuticals Bond ETF tracks the performance of the Bloomberg Barclays US Corporate 15+ Year Pharmaceuticals Index - Benchmark TR Net.

Fuh Hwa 15+ Year Pharmaceuticals Bond ETF is domiciled in TW.

The fund was launched on 11/2/2018.

The Fuh Hwa 15+ Year Pharmaceuticals Bond ETF mainly invests in Wide credit companies.

The NAV of Fuh Hwa 15+ Year Pharmaceuticals Bond ETF amounts to 55.81 M TWD.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.